Deadline Date: June 30, 2026
The Biotechnology Industry Research Assistance Council (BIRAC) is inviting applications for its Product Commercialization Program Fund (PCP Fund), an initiative designed to support Indian biotech startups and enterprises in taking validated products or technologies to the market.
This scheme is tailored for innovations that have already reached a mature technology readiness level and require resources to scale up, validate in real‑world settings, or begin commercial production. By providing this bridge between lab‑ready prototypes and market launch, the PCP Fund helps emerging biotech firms surmount a critical hurdle in turning scientific ideas into accessible, usable solutions.
Under the PCP Fund, selected companies receive grant support for a limited duration — typically up to 24 months — to manage activities such as production scale-up, pilot manufacturing, validation studies, and regulatory readiness. The fund is structured to encourage responsible commercialization: there is a benefit‑sharing mechanism in which recipient companies share a portion of the financial gains back with BIRAC once the product begins to generate revenue, ensuring that public investment is reinvested into future innovation.
The Program is open exclusively to Indian entities — including startups, small enterprises, and technology firms working in biotechnology — that have developed a technology to a high maturity stage and are ready for pre‑commercial or commercial deployment. Applicants must propose well-defined commercialization plans, including technical, financial, and market strategies, and demonstrate readiness to meet regulatory, manufacturing, and distribution challenges.
By offering this focused financial and strategic support, the PCP Fund plays a vital role in India’s biotech innovation ecosystem. It helps de-risk the final steps of bringing biotech products — whether diagnostics, therapeutics, green‑technology bio‑solutions, or industrial biomanufacturing — to the market. For firms that have successfully demonstrated proof of concept and are ready to move toward real‑world application, this call represents a powerful opportunity to turn scientific promise into tangible, scalable impact.
For more information, visit BIRAC.
